125 related articles for article (PubMed ID: 11302341)
1. Differentiation of radiographically indeterminate solitary pulmonary nodules with.
Hung GU; Shiau YC; Tsai SC; Ho YJ; Kao CH; Yen RF
Jpn J Clin Oncol; 2001 Feb; 31(2):51-4. PubMed ID: 11302341
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
3. Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Hsu WH; Hsu NY; Shen YY; Yen RF; Kao CH
Cancer Invest; 2003; 21(1):47-52. PubMed ID: 12643009
[TBL] [Abstract][Full Text] [Related]
4. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Gupta NC; Maloof J; Gunel E
J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
6. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
8. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Gupta NC; Frank AR; Dewan NA; Redepenning LS; Rothberg ML; Mailliard JA; Phalen JJ; Sunderland JJ; Frick MP
Radiology; 1992 Aug; 184(2):441-4. PubMed ID: 1620844
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
11. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
13.
Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
[TBL] [Abstract][Full Text] [Related]
14. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
[TBL] [Abstract][Full Text] [Related]
15. Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography--a preliminary report.
Chang CH; Shiau YC; Shen YY; Kao A; Lin CC; Lee CC
Urol Int; 2003; 71(3):306-9. PubMed ID: 14512653
[TBL] [Abstract][Full Text] [Related]
16. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
[TBL] [Abstract][Full Text] [Related]
17. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
18. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.
Sathekge MM; Maes A; Pottel H; Stoltz A; van de Wiele C
S Afr Med J; 2010 Sep; 100(9):598-601. PubMed ID: 20822650
[TBL] [Abstract][Full Text] [Related]
19. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
Herder GJ; Golding RP; Hoekstra OS; Comans EF; Teule GJ; Postmus PE; Smit EF
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1231-6. PubMed ID: 15175835
[TBL] [Abstract][Full Text] [Related]
20. [Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions].
Ruiz-Hernández G; de Juan R; Samanes A; Verea H; Peñas JM; Veres A; Lapeña L; Montz R; Carreras JL
An Med Interna; 2004 Jan; 21(1):12-6. PubMed ID: 15195479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]